Cannabis Use Linked to Lower Methadone Blood Levels in Opioid Treatment | Research

The takeaway

Among patients in methadone maintenance treatment, cannabis users had significantly lower methadone blood levels than non-users even after adjusting for dose, which could affect treatment effectiveness.

Read this if you use cannabis while on methadone maintenance treatment.

Above 200 ng/ml l-methadone: zero heroin use reported

What the researchers found

Researchers measured blood levels of the active form of methadone (l-methadone) in 94 opioid-dependent patients on maintenance treatment. They found that above 200 ng/ml, no patients reported heroin use, and above 250 ng/ml, craving was absent.

A key secondary finding was that cannabis users had significantly lower plasma l-methadone concentrations compared to non-users, even after adjusting for methadone dosage. This suggests a pharmacokinetic interaction where cannabis may accelerate methadone metabolism.

Other protective factors against heroin use included older age, stable employment, and being married.

Why it matters

If cannabis use lowers methadone blood levels, it could reduce methadone treatment effectiveness and contribute to continued opioid use. This has practical implications for dosing decisions in patients who also use cannabis.

The numbers in context

94 patients; above 200 ng/ml l-methadone: no heroin use; above 250 ng/ml: no craving; 54.2% achieved 100-250 ng/ml at doses of 60+ mg/day; cannabis users had significantly lower l-methadone levels (p<0.05)

How the study worked

Cross-sectional study of 94 consecutively recruited patients in methadone maintenance. Blood was drawn for l-methadone concentration, and urine analyses over the prior three weeks determined treatment response. Cannabis use was documented alongside demographic and dosing data.

What this study cannot tell us

Cross-sectional design cannot establish causation. Small sample. Cannabis use was self-reported. The mechanism for lower methadone levels was not determined. Could reflect differences in metabolism, adherence, or other unmeasured factors.

How to read the evidence

Small cross-sectional study identifying an association. Important clinical observation but requires replication and mechanistic investigation.

When this study was published

Published in 2015. Cannabis-drug interactions remain under-studied in addiction medicine.

The bigger picture

Drug interactions between cannabis and medications are an increasingly important clinical concern. This finding suggests clinicians managing methadone treatment should consider cannabis use when adjusting doses, though the mechanism needs further study.

Questions still open

Does cannabis actually accelerate methadone metabolism? Would dose adjustments in cannabis-using patients improve treatment outcomes? Is this interaction specific to methadone or does it affect other opioid medications?

Common questions

Does cannabis interfere with methadone treatment?

This study found that cannabis users had lower methadone blood levels, which could reduce treatment effectiveness. The mechanism is unclear but may involve cannabis affecting how the body metabolizes methadone.

What methadone blood level is needed for treatment to work?

The study found that above 200 ng/ml of l-methadone, no patients used heroin, and above 250 ng/ml, craving was absent. However, only about 54% of patients on adequate doses (60+ mg/day) achieved levels in the 100-250 ng/ml range.

Read the original research

Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.

European journal of pharmacology, 760, 1-6

View on PubMed ↗Publisher’s paper ↗

Citation

Meini, Milo; Moncini, Marco; Daini, Laura; Giarratana, Tania; Scaramelli, Daniela; Chericoni, Silvio; Stefanelli, Fabio; Rucci, Paola. (2015). Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.. European journal of pharmacology, 760, 1-6. https://doi.org/10.1016/j.ejphar.2015.03.081